EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer-Reference-Cited by-同舟云学术

EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer

Published:2018-12 Issue: Volume:82 Page:163-171
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Birkman Eva-Maria,Avoranta Tuulia,Ålgars Annika,Korkeila Eija,Lintunen Minnamaija,Lahtinen Laura,Kuopio Teijo,Ristamäki Raija,Carpén Olli,Sundström Jari

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference29 articles.

1. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008

2. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer;Lièvre;Cancer Res,2006

3. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J Clin Oncol,2008

4. Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non–small-cell lung cancer and metastatic colorectal cancer;Linardou;Lancet Oncol,2008

5. Extended RAS gene mutation testing in metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy: American Society of Clinical Oncology provisional clinical opinion update 2015;Allegra;J Clin Oncol,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance;Molecules;2022-07-25

2. Copy Number Variation and Rearrangements Assessment in Cancer: Comparison of Droplet Digital PCR with the Current Approaches;International Journal of Molecular Sciences;2021-04-29